Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease

A large body of evidence indicates that sporadic Alzheimer’s disease (AD) is a vascular disorder with neurodegenerative consequences and needs to be treated and managed as such. Epidemiologic studies

[1]  M. Novotná.  [Results of a longitudinal study]. , 1974, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete.

[2]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[3]  Richard S. J. Frackowiak,et al.  Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.

[4]  R. Frackowiak,et al.  Cerebral blood flow and metabolism studies in multi-infarct dementia. , 1991, Alzheimer disease and associated disorders.

[5]  B. Pappas,et al.  Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats , 1992, Brain Research.

[6]  J. C. de la Torre,et al.  Can disturbed brain microcirculation cause Alzheimer's disease? , 1993, Neurological research.

[7]  R. D'Agostino,et al.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.

[8]  R. Mayeux,et al.  Risk of dementia after stroke in a hospitalized cohort , 1994, Neurology.

[9]  T. Fortin,et al.  Correlates between nuclear magnetic resonance spectroscopy, diffusion weighted imaging and CA1 morphometry following chronic brain ischemia , 1995, Journal of neuroscience research.

[10]  M. Moskowitz,et al.  Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[12]  B L Holman,et al.  Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.

[13]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[14]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[15]  A. Hudetz,et al.  Production of 20-HETE and its role in autoregulation of cerebral blood flow. , 2000, Circulation research.

[16]  J. C. Torre,et al.  Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis , 2000, Neurobiology of Aging.

[17]  M. Phelps,et al.  Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. , 2001, Molecular genetics and metabolism.

[18]  M. Fujishima,et al.  Incidence and Risk Factors of Dementia in a Defined Elderly Japanese Population , 2002 .

[19]  J. Merino.  Dementia after stroke: high incidence and intriguing associations. , 2002, Stroke.

[20]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[21]  A. J. Maxwell.  Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. , 2002, Nitric oxide : biology and chemistry.

[22]  J. C. Torre,et al.  Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .

[23]  Y. Stern,et al.  Incidence of Dementia After Ischemic Stroke: Results of a Longitudinal Study , 2002, Stroke.

[24]  J. Miklossy.  Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease , 2003, Neurological research.

[25]  J. C. de la Torre,et al.  For Personal Use. Only Reproduce with Permission the Lancet Publishing Group. Personal View Is Ad Neurodegenerative or Vascular? Is Ad Neurodegenerative? Is Alzheimer's Disease a Neurodegenerative or a Vascular Disorder? Data, Dogma, and Dialectics , 2022 .

[26]  Sudha Seshadri,et al.  Dementia After Stroke: The Framingham Study , 2004, Stroke.

[27]  J. C. de la Torre,et al.  Alzheimer's disease is a vasocognopathy: a new term to describe its nature , 2004, Neurological research.

[28]  A. Hofman,et al.  Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.

[29]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[30]  M. Takeda,et al.  Molecular genetics of Alzheimer's disease and aging. , 2005, Methods and findings in experimental and clinical pharmacology.

[31]  R. Vassar,et al.  Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  D. Sparks,et al.  Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. , 2005, Archives of general psychiatry.

[33]  Frederik Barkhof,et al.  Blood Pressure, White Matter Lesions and Medial Temporal Lobe Atrophy: Closing the Gap between Vascular Pathology and Alzheimer’s Disease? , 2005, Dementia and Geriatric Cognitive Disorders.

[34]  Miia Kivipelto,et al.  Rethinking the Dementia Diagnoses in a Population-Based Study: What Is Alzheimer’s Disease and What Is Vascular Dementia? , 2006, Dementia and Geriatric Cognitive Disorders.

[35]  R. Martins,et al.  Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease , 2006, Molecular Psychiatry.

[36]  P. Zandi,et al.  Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study , 2006, Alzheimer disease and associated disorders.

[37]  Geraldo F. Busatto,et al.  Regional cerebral blood flow reductions, heart failure and Alzheimer's disease , 2006, Neurological research.

[38]  The deadly triad: heart disease, stroke and Alzheimer's disease , 2006 .

[39]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[40]  P. Zandi,et al.  Cholesterol and Alzheimer's disease—is there a relation? , 2006, Mechanisms of Ageing and Development.

[41]  K. Blennow,et al.  Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[42]  S. Santi,et al.  Hippocampal hypometabolism predicts cognitive decline from normal aging , 2008, Neurobiology of Aging.